Page breadcrumb nav

VAERS Report 2156585

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-10
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

tachycardia; asthenia; pain; pyrexia; chills; dysstasia; palpitations; this is a spontaneous report received from a contactable reporter (consumer or other non hcp) from the regulatory authority. the reporter is the patient. other case identifier: gb-mhra-vac-202202121025375070-6q93j (ra) and gb-mhra-adr 26597666 (ra). a 68-year-old female patient received bnt162b2 (comirnaty), administration date 10feb2022 (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunization. relevant medical history included: "adverse drug reaction" (unknown if ongoing), notes: tazacin, cephdazamine and gentamycin. the patient's concomitant medications were not reported. past drug history included: tazocin; ceftazidime and gentamycin. vaccination history included: covid-19 vaccine astrazeneca (dose 1, single) for covid-19 immunization, reaction: "had no reaction"; bnt162b2 (dose 2 (initial pfizer dose), single), for covid-19 immunization, reactions: "interchange of vaccine products" and "felt ill for a week". the following information was reported: tachycardia (medically significant) with onset 12feb2022, outcome "unknown", described as "tachycardia"; asthenia (medically significant) with onset 12feb2022, outcome "unknown", described as "asthenia"; pain (medically significant) with onset 12feb2022, outcome "unknown", described as "pain"; pyrexia (medically significant) with onset 12feb2022, outcome "unknown", described as "pyrexia"; chills (medically significant) with onset 12feb2022, outcome "unknown", described as "chills"; palpitations (medically significant) with onset feb2022, outcome "unknown", described as "palpitations"; dysstasia (medically significant) with onset 12feb2022, outcome "unknown", described as "dysstasia". it was reported that within 12 hours of vaccination, the patient felt weak, achy and was unable to stand for long. that evening the patient had pyrexia and shivering badly. at 02:00, the patient woke with a severe tachycardia and was too weak to move. after half an hour of hesitating about calling, the patient's heart rate came down to 95 and oxygen saturation (sats) were reported as 92. the morning of the day of report, the patient still found difficult to stand or do anything. the patient heart races when she tried to move for toilet. this was regarding the patient's second pfizer vaccine. the patient felt ill for a week after the first vaccination with bnt162b2 but without any cardiac issues. the patient had no reaction to astrazeneca vaccine. the patient underwent the following laboratory tests and procedures: heart rate: 95 and oxygen saturation: 92. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
test name: heart rate; result unstructured data: test result:95; test name: oxygen saturation; result unstructured data: test result:92
Liste des symptômes
chills pain asthenia tachycardia palpitations pyrexia dysstasia heart rate oxygen saturation
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na